During the past decade, Selye Janos Korhaz conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 5 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Selye Janos Korhaz" #1 sponsor was "Bayer" with 3 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Amgen" with 2 trials sponsored, "Artu Biologicals" with 2 trials sponsored and "Arrowhead Pharmaceuticals" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Selye Janos Korhaz" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Selye Janos Korhaz" are "Allergic Rhinoconjunctivitis" (2 trials), "Atrial Fibrillation" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Heart Failure" (2 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Selye Janos Korhaz" in a lesser frequency.

Most popular intervention types in "Selye Janos Korhaz" are "Drug" (15 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Empagliflozin" (2 trials), "Oralgen" (2 trials), "ARO-APOC3" (1 trials) and "Apabetalone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Selye Janos Korhaz" are 14 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Selye Janos Korhaz". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Selye Janos Korhaz, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Selye Janos Korhaz, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".